MX2023002691A - Desimetrización de diol mediante sustitución aromática nucleófila. - Google Patents
Desimetrización de diol mediante sustitución aromática nucleófila.Info
- Publication number
- MX2023002691A MX2023002691A MX2023002691A MX2023002691A MX2023002691A MX 2023002691 A MX2023002691 A MX 2023002691A MX 2023002691 A MX2023002691 A MX 2023002691A MX 2023002691 A MX2023002691 A MX 2023002691A MX 2023002691 A MX2023002691 A MX 2023002691A
- Authority
- MX
- Mexico
- Prior art keywords
- desymmetrization
- diol
- aromatic substitution
- nucleophilic aromatic
- compound
- Prior art date
Links
- 238000010596 desymmetrization reaction Methods 0.000 title 1
- 150000002009 diols Chemical class 0.000 title 1
- 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000012453 solvate Substances 0.000 abstract 3
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- SFHYNDMGZXWXBU-LIMNOBDPSA-N 6-amino-2-[[(e)-(3-formylphenyl)methylideneamino]carbamoylamino]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1C(C2=3)=CC(S(O)(=O)=O)=CC=3C(N)=C(S(O)(=O)=O)C=C2C(=O)N1NC(=O)N\N=C\C1=CC=CC(C=O)=C1 SFHYNDMGZXWXBU-LIMNOBDPSA-N 0.000 abstract 1
- 101001056180 Homo sapiens Induced myeloid leukemia cell differentiation protein Mcl-1 Proteins 0.000 abstract 1
- 102100026539 Induced myeloid leukemia cell differentiation protein Mcl-1 Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Se proporcionan en la presente procesos para sintetizar inhibidores de Mcl-1 y productos intermedios tales como el compuesto Y que pueden usarse para prepararlos, donde el R1 variable es tal como se define en la presente. En particular, se proporcionan en la presente procesos para sintetizar el compuesto A1, y sales o solvatos del mismo, el compuesto A2, y sales y solvatos del mismo, y el compuesto A3 y sales y solvatos del mismo.(ver fórmulas).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063074241P | 2020-09-03 | 2020-09-03 | |
PCT/US2021/048588 WO2022051317A1 (en) | 2020-09-03 | 2021-09-01 | Diol desymmetrization by nucleophilic aromatic substitution |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023002691A true MX2023002691A (es) | 2023-05-03 |
Family
ID=77924515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023002691A MX2023002691A (es) | 2020-09-03 | 2021-09-01 | Desimetrización de diol mediante sustitución aromática nucleófila. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230365588A1 (es) |
EP (1) | EP4208467A1 (es) |
JP (1) | JP2023540083A (es) |
KR (1) | KR20230058694A (es) |
CN (1) | CN116249705A (es) |
AU (1) | AU2021337589A1 (es) |
CA (1) | CA3193132A1 (es) |
CL (1) | CL2023000605A1 (es) |
IL (1) | IL300977A (es) |
MX (1) | MX2023002691A (es) |
WO (1) | WO2022051317A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020391106B2 (en) | 2019-11-26 | 2024-03-21 | Gilead Sciences, Inc. | Processes and intermediates for preparing MCL1 inhibitors |
CN116457334A (zh) * | 2020-11-19 | 2023-07-18 | 吉利德科学公司 | 用于制备大环mcl1抑制剂的方法和中间体 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3474B1 (ar) | 2014-08-29 | 2020-07-05 | Amgen Inc | مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1 |
JP6453507B2 (ja) | 2017-03-30 | 2019-01-16 | アムジエン・インコーポレーテツド | Mcl−1タンパク質を阻害する化合物 |
TWI745836B (zh) * | 2019-01-18 | 2021-11-11 | 大陸商蘇州亞盛藥業有限公司 | 作為mcl-1抑製劑的大螺環醚 |
-
2021
- 2021-09-01 EP EP21778303.4A patent/EP4208467A1/en active Pending
- 2021-09-01 KR KR1020237010991A patent/KR20230058694A/ko unknown
- 2021-09-01 CA CA3193132A patent/CA3193132A1/en active Pending
- 2021-09-01 CN CN202180065223.4A patent/CN116249705A/zh active Pending
- 2021-09-01 US US18/024,716 patent/US20230365588A1/en active Pending
- 2021-09-01 IL IL300977A patent/IL300977A/en unknown
- 2021-09-01 MX MX2023002691A patent/MX2023002691A/es unknown
- 2021-09-01 WO PCT/US2021/048588 patent/WO2022051317A1/en active Application Filing
- 2021-09-01 JP JP2023513981A patent/JP2023540083A/ja active Pending
- 2021-09-01 AU AU2021337589A patent/AU2021337589A1/en active Pending
-
2023
- 2023-03-02 CL CL2023000605A patent/CL2023000605A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP4208467A1 (en) | 2023-07-12 |
JP2023540083A (ja) | 2023-09-21 |
CA3193132A1 (en) | 2022-03-10 |
IL300977A (en) | 2023-04-01 |
KR20230058694A (ko) | 2023-05-03 |
AU2021337589A1 (en) | 2023-03-30 |
US20230365588A1 (en) | 2023-11-16 |
WO2022051317A1 (en) | 2022-03-10 |
CL2023000605A1 (es) | 2023-08-11 |
CN116249705A (zh) | 2023-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000795A (es) | Compuestos heterociclicos para inhibir la actividad de shp2. | |
AU2019231551A8 (en) | Substituted 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones | |
MX2021005714A (es) | Nuevos compuestos heterociclicos. | |
MX2023002691A (es) | Desimetrización de diol mediante sustitución aromática nucleófila. | |
MX2022005726A (es) | Sintesis mejorada del compuesto inhibidor de g12c de kras. | |
MX2020009234A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos. | |
TW200745066A (en) | Novel PTP1B inhibitors | |
WO2021011713A8 (en) | Imidazopyrimidines as eed inhibitors and the use thereof | |
MX2019009653A (es) | Inhibidores de mnk sustituidos con piperidina y metodos relacionados con los mismos. | |
MX2020007565A (es) | Nuevos oxadiazoles. | |
MX2021012325A (es) | Nuevos compuestos de oxadiazol para controlar o prevenir hongos fitopatogénicos. | |
MX2021003843A (es) | Inhibidores de la interaccion yap/taz-tead y su uso en el tratamiento del cancer. | |
CR20220116A (es) | Compuestos heterocíclicos | |
MX2021011286A (es) | Compuestos de heterociclil(fenil)metanol útiles en el tratamiento de la hiperglucemia. | |
MX2021003427A (es) | Nuevos oxadiazoles. | |
CR20220004A (es) | Nuevos compuestos heterocíclicos | |
MX2021012278A (es) | Azinas condensadas para la modulacion de ep300 o cbp e indicaciones de estos. | |
MX2020012760A (es) | Nuevos compuestos de piridina y pirazina como inhibidores del receptor cannabinoide 2. | |
MX2020006370A (es) | Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas. | |
MX2021014680A (es) | Derivado de benzotriazol. | |
MX2021012326A (es) | Nuevos compuestos de oxidazol para controlar o prevenir hongos fitopatogenicos. | |
CR20220478A (es) | Derivados de benzodiazepinas como pam de gaba a gamma 1 | |
JOP20220125A1 (ar) | مركبات حلقية غير متجانسة على هيئة مثبطات دلتا-5 ديساتوراز وطرق لاستخدامها | |
CR20220139A (es) | Inhibidor de diacilglicerol aciltransferasa 2 | |
MX2021009142A (es) | Inhibidores topicos de fosfoinositol 3-cinasas. |